Summary & Overview
Cesarean Section with Sterilization with CC: Inpatient Reimbursement Overview
DRG 784 applies to cesarean section with concurrent sterilization when a Complication or Comorbidity is documented, covering the operative delivery and related inpatient care. It matters for inpatient reimbursement because the documented complication or comorbidity increases the Diagnosis-Related Group severity level and influences Medicare payment for the hospitalization.
DRG 784 Overview
DRG 784 covers inpatient admissions for cesarean section combined with female sterilization when a Complication or Comorbidity is present. It encompasses surgical delivery with concurrent sterilization procedures and associated perioperative care, including anesthesia and postpartum management. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity increases resource use and adjusts the reimbursement relative to lower-severity groupings. Accurate coding of the cesarean, sterilization, and any Complication or Comorbidity is therefore critical to match payment to clinical complexity.
Clinical Trials
- Perioperative management and infection prevention trials: randomized or quasi-experimental studies testing surgical site infection reduction bundles, antibiotic timing/duration protocols, and perioperative glucose control specifically in women undergoing cesarean section with concurrent sterilization. These studies enroll pregnant women scheduled for cesarean delivery who elect or require tubal sterilization at the same operation, and they measure intra- and postoperative infection rates, wound healing, and short-term maternal morbidity. Results inform protocols that can reduce complications, length of stay, and readmissions—key drivers of cost and quality for hospitals and payers managing this DRG.
- Comparative effectiveness studies of anesthesia and analgesia strategies: observational cohorts or pragmatic trials comparing spinal versus combined spinal-epidural techniques, adjunct opioid-sparing regimens, and multimodal postoperative pain pathways in cesarean deliveries that include sterilization. These studies focus on maternal outcomes such as pain control, mobility, breastfeeding initiation, and opioid consumption in the immediate inpatient period and during the first weeks postpartum. Findings help clinicians choose anesthesia and pain-management approaches that optimize recovery and may reduce inpatient resource use and downstream outpatient opioid-related care, affecting reimbursement and care pathways for this patient group.
- Post-discharge maternal and reproductive outcomes research: prospective registries or longitudinal cohort studies following women who had cesarean with sterilization to evaluate longer-term outcomes such as tubal sterilization success/failure, menstrual or pelvic pain sequelae, mental health and satisfaction with contraceptive counseling, and healthcare utilization up to one year postpartum. These studies enroll patients at discharge and collect data on subsequent gynecologic visits, reoperations, contraceptive-related complications, and quality-of-life metrics. Payers and providers use this evidence to understand readmission risks, coding and payment implications, and the value of perioperative counseling or follow-up programs targeted to this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.